9.159.1163 Boehringer Ingelheim Investigational Site — Stony Brook, New York

9.159.1163 Boehringer Ingelheim Investigational Site is a clinical research site located in Stony Brook, New York, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

9.159.1163 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Stroke.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stony Brook

Browse all research sites in New York · View every site in Stony Brook

• State University of New York at
• Emergency Medicine Stony Brook University Hospital
• Stony Brook University and Medical Center
• Stony Brook Hospital and Medical Center
• Stony Brook University Medical Center, Dept. of Neurological Surgery
• Division of Hematology/Oncology, Stony Brook University Hospital
• University Hospital - Stony Brook
• Stony Brook University Medical Center, Vein Clinic
• University Hospital State University of New York at Stony Brook Department of Pediatrics
• Suny At Stony Brook University Medical Center
• State University of NY at Stonybrook
• Administrative Center/Study Chair's Office: Stony Brook University

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 9.159.1163 Boehringer Ingelheim Investigational Site?

9.159.1163 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 9.159.1163 Boehringer Ingelheim Investigational Site conducted?

9.159.1163 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Stroke.

Is 9.159.1163 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

9.159.1163 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 9.159.1163 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.